Filing Details
- Accession Number:
- 0001035267-24-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-08 14:06:44
- Reporting Period:
- 2024-02-07
- Accepted Time:
- 2024-02-08 14:06:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1035267 | Intuitive Surgical Inc | ISRG | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 770416458 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1519593 | J. David Rosa | 1020 Kifer Road Sunnyvale CA 94086 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-07 | 22,050 | $59.23 | 176,299 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-07 | 12,900 | $389.29 | 163,399 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-07 | 22,050 | $57.11 | 185,449 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-07 | 12,840 | $389.30 | 172,609 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-07 | 28,125 | $51.02 | 200,734 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-07 | 16,150 | $389.23 | 184,584 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-07 | 40,500 | $49.09 | 225,084 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-07 | 23,120 | $389.28 | 201,964 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-07 | 28,125 | $49.34 | 230,089 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-07 | 15,700 | $389.29 | 214,389 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-07 | 40,500 | $0.00 | 40,500 | $49.09 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-07 | 28,125 | $0.00 | 28,125 | $49.34 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-07 | 28,125 | $0.00 | 28,125 | $51.02 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-07 | 22,050 | $0.00 | 22,050 | $57.11 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-07 | 22,050 | $0.00 | 22,050 | $59.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-08-07 | No | 4 | M | Direct | |
| 0 | 2024-02-18 | No | 4 | M | Direct | |
| 0 | 2024-08-15 | No | 4 | M | Direct | |
| 0 | 2025-02-17 | No | 4 | M | Direct | |
| 0 | 2025-08-17 | No | 4 | M | Direct |
Footnotes
- These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2025.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,000 shares sold at $386.61 to $387.54; 2,050 shares sold at $387.70 to $388.67; 6,109 shares sold at $388.80 to $389.76; 3,201 shares sold at $389.84 to $390.61; and 540 shares sold at $390.91 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,100 shares sold at $386.61 to $387.54; 1,900 shares sold at $387.70 to $388.67; 5,974 shares sold at $388.80 to $389.75; 3,526 shares sold at $389.84 to $390.79; and 340 shares sold at $390.96 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,712 shares sold at $386.61 to $387.37; 2,350 shares sold at $387.70 to $388.42; 7,354 shares sold at $388.80 to $389.77; 4,094 shares sold at $389.84 to $390.73; and 640 shares sold at $390.91 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $392.00 as follows: 2,057 shares sold at $386.61 to $387.37; 3,377 shares sold at $387.70 to $388.69; 10,942 shares sold at $388.77 to $389.77; 5,904 shares sold at $389.79 to $390.79; 740 shares sold at $390.91 to $391.57; and 100 shares sold at $392.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57as follows: 1,300 shares sold at $386.61 to $387.54; 2,400 shares sold at $387.70 to $388.67; 7,622 shares sold at $388.77 to $389.75; 3,938 shares sold at $389.84 to $390.79; and 440 shares sold at $390.96 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
- Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
Billionaire Hedge Funds
